GEP20104908B - Use of palonosetron treating post-operative nausea and vomiting - Google Patents

Use of palonosetron treating post-operative nausea and vomiting

Info

Publication number
GEP20104908B
GEP20104908B GEAP20048984A GEAP2004008984A GEP20104908B GE P20104908 B GEP20104908 B GE P20104908B GE AP20048984 A GEAP20048984 A GE AP20048984A GE AP2004008984 A GEAP2004008984 A GE AP2004008984A GE P20104908 B GEP20104908 B GE P20104908B
Authority
GE
Georgia
Prior art keywords
vomiting
palonosetron
operative nausea
treating post
post
Prior art date
Application number
GEAP20048984A
Other languages
English (en)
Inventor
Riccardo Braglia
Enrico Braglia
Alberto Macciocchi
Luigi Baroni
Original Assignee
Helsinn Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32908576&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GEP20104908(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa
Publication of GEP20104908B publication Critical patent/GEP20104908B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
GEAP20048984A 2003-02-18 2004-02-18 Use of palonosetron treating post-operative nausea and vomiting GEP20104908B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US44834203P 2003-02-18 2003-02-18

Publications (1)

Publication Number Publication Date
GEP20104908B true GEP20104908B (en) 2010-03-10

Family

ID=32908576

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAP20048984A GEP20104908B (en) 2003-02-18 2004-02-18 Use of palonosetron treating post-operative nausea and vomiting

Country Status (31)

Country Link
US (1) US20060074101A1 (enExample)
EP (2) EP2258367A3 (enExample)
JP (1) JP2006517944A (enExample)
KR (1) KR101113087B1 (enExample)
CN (1) CN1750822A (enExample)
AT (1) ATE490774T1 (enExample)
AU (1) AU2004212704B2 (enExample)
BR (1) BRPI0407549A (enExample)
CA (1) CA2515946C (enExample)
CU (1) CU23587B7 (enExample)
CY (1) CY1111312T1 (enExample)
DE (1) DE602004030424D1 (enExample)
DK (1) DK1596862T3 (enExample)
EA (1) EA013836B1 (enExample)
EC (1) ECSP055970A (enExample)
ES (1) ES2357769T3 (enExample)
GE (1) GEP20104908B (enExample)
HR (1) HRP20050709A2 (enExample)
IS (1) IS7983A (enExample)
MX (1) MXPA05008757A (enExample)
MY (1) MY143789A (enExample)
NO (1) NO20054296L (enExample)
NZ (1) NZ541862A (enExample)
PL (1) PL378122A1 (enExample)
PT (1) PT1596862E (enExample)
SI (1) SI1596862T1 (enExample)
TW (1) TWI355936B (enExample)
UA (1) UA96254C2 (enExample)
UY (1) UY28193A1 (enExample)
WO (1) WO2004073714A1 (enExample)
ZA (1) ZA200506580B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
RU2490012C2 (ru) * 2006-01-27 2013-08-20 Апталис Фарматех Инк Системы доставки лекарственного средства, содержащие слабощелочной селективный 5-ht3, серотониновый блокатор и органические кислоты
AU2007211101B2 (en) * 2006-01-27 2013-05-02 Adare Pharmaceuticals, Inc. Drug delivery systems comprising weakly basic drugs and organic acids
ES2325339T3 (es) * 2006-10-24 2009-09-01 Helsinn Healthcare S.A. Capsulas blandas que comprenden hidrocloruro de palonosetron que tienen una estabilidad y una biodisponibilidad mejoradas.
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
US20090155363A1 (en) * 2007-12-14 2009-06-18 Todd Maibach Methods for oral administration of active drugs
WO2009139411A1 (ja) 2008-05-15 2009-11-19 久光製薬株式会社 パロノセトロンを含有する経皮吸収製剤
EP2364138A2 (en) * 2008-12-08 2011-09-14 Teva Pharmaceutical Industries Ltd. Palonosetron formulation
EP2253316B1 (en) * 2009-05-20 2013-08-14 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of an inner ear pathology with vestibular deficits
RU2608458C2 (ru) 2009-05-20 2017-01-18 Инсерм (Энститю Насьональ Де Ля Сантэ Э Де Ля Решерш Медикаль) Антагонисты серотониновых 5-нт3-рецепторов для применения при лечении вестибулярных нарушений с повреждениями
US20110003005A1 (en) * 2009-07-06 2011-01-06 Gopi Venkatesh Methods of Treating PDNV and PONV with Extended Release Ondansetron Compositions
WO2011058427A1 (en) 2009-11-13 2011-05-19 Helsinn Healthcare S.A. Palonosetron metabolites
ES2623503T3 (es) 2009-11-18 2017-07-11 Helsinn Healthcare Sa Composiciones para tratar náuseas y vómitos mediados centralmente
EP2722045B1 (en) 2009-11-18 2016-07-06 Helsinn Healthcare SA Compositions for treating centrally mediated nausea and vomiting
KR101368587B1 (ko) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 오심 또는 구토 방지용 조성물
WO2014004126A1 (en) 2012-06-26 2014-01-03 Fleming C Andrew Treating postoperative nausea and vomiting
WO2015099381A1 (ko) 2013-12-23 2015-07-02 주식회사 삼양바이오팜 팔로노세트론을 함유하는 약학 조성물
ES2975016T3 (es) 2016-04-14 2024-07-02 Sensorion (+)-Azasetrón para uso en el tratamiento de trastornos del oído
JP6768404B2 (ja) * 2016-08-12 2020-10-14 武田テバファーマ株式会社 パロノセトロン又はその薬学的に許容される塩を含む医薬組成物
JP6705348B2 (ja) * 2016-09-23 2020-06-03 ニプロ株式会社 液体製剤、及び、パロノセトロンの安定性を向上する方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
KR101802183B1 (ko) * 2016-11-16 2017-11-28 주식회사 유영제약 팔로노세트론을 활성성분으로 함유하는 약제학적 조성물
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
HRP20230471T1 (hr) * 2018-01-12 2023-07-21 Orion Corporation Palonsetron kapi za oči za liječenje ili prevenciju mučnine i povraćanja
CN108703960A (zh) * 2018-07-25 2018-10-26 无锡鑫连鑫生物医药科技有限公司 一种帕洛诺司琼缓释微球及其制备方法和使用方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695578A (en) 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
US4937247A (en) 1985-04-27 1990-06-26 Beecham Group P.L.C. 1-acyl indazoles
EP0200444B1 (en) 1985-04-27 1992-11-11 Beecham Group Plc Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
US5578628A (en) 1985-06-25 1996-11-26 Glaxo Group Limited Medicaments for the treatment of nausea and vomiting
US5240954A (en) 1985-06-25 1993-08-31 Glaxo Group Limited Medicaments
GB8516083D0 (en) 1985-06-25 1985-07-31 Glaxo Group Ltd Heterocyclic compounds
US4906755A (en) 1986-11-03 1990-03-06 Merrell Dow Pharmaceuticals Inc. Esters of hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3-(4H)-one and related compounds
US4707484A (en) 1986-11-25 1987-11-17 Hoffmann-La Roche Inc. Substituted piperidinomethylindolone and cyclopent(b)indolone derivatives
US5011846A (en) 1988-02-23 1991-04-30 Merrell Dow Pharmaceuticals Inc. Medicament compositions derived from quinolizine and quinolizinone and methods of use thereof
US5344658A (en) * 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
GB8914804D0 (en) * 1989-06-28 1989-08-16 Glaxo Group Ltd Process
DK0430190T3 (da) 1989-11-28 1995-08-21 Syntex Inc Hidtil ukendte tricykliske forbindelser
US5189041A (en) 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
US5137893A (en) 1991-03-07 1992-08-11 G. D. Searle & Co. Pharmaceutically useful meso-azacyclic amides of imidazopyridine carboxylic acids and analogs thereof
US5491148A (en) 1991-04-26 1996-02-13 Syntex (U.S.A.) Inc. Isoquinolinone and dihydroisoquinolinone 5-HT3 receptor antagonists
US5272137A (en) * 1992-02-14 1993-12-21 Mcneil-Pfc, Inc. Aqueous pharmaceutical suspension for pharmaceutical actives
GB9305593D0 (en) 1993-03-18 1993-05-05 Smithkline Beecham Plc Pharmaceuticals
US5492914A (en) 1994-07-28 1996-02-20 Syntex (U.S.A.) Inc. 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]is[2.2.2]oct-3's-yl)-6-hydroxy-2,3,3a,4,5,6-hexahydro-1h-benz [DE]isoquinolin-1-one and individual stereoisomers thereof
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423588D0 (en) * 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9625589D0 (en) * 1996-12-10 1997-01-29 Boots Co Plc Therapeutic agents
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US6294548B1 (en) 1998-05-04 2001-09-25 Hoffmann-La Roche Inc. Multidose vial formulations for administering endo-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-1-methyl-1H-indazole-3-carboxamide hydrochloride
WO1999064046A1 (en) * 1998-06-08 1999-12-16 Advanced Medicine, Inc. Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5-ht3 receptors
DE69904498T2 (de) * 1998-10-27 2003-04-24 Alcon Laboratories, Inc. Konservierungsmittel für lokale pharmazeutische zubereitungen enthaltend eine fettsäure/aminosäure enthaltende seife
US6196963B1 (en) * 1999-03-02 2001-03-06 Medtronic Ave, Inc. Brachytherapy device assembly and method of use
AU2003237657A1 (en) * 2002-05-24 2003-12-12 Epidauros Biotechnologie Ag Means and methods for improved treatment using "setrones"
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
US8598219B2 (en) * 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone

Also Published As

Publication number Publication date
KR20050121671A (ko) 2005-12-27
CN1750822A (zh) 2006-03-22
TW200418474A (en) 2004-10-01
AU2004212704A1 (en) 2004-09-02
CA2515946C (en) 2008-12-02
WO2004073714A1 (en) 2004-09-02
CA2515946A1 (en) 2004-09-02
EP2258367A3 (en) 2011-07-13
PL378122A1 (pl) 2006-03-06
NO20054296L (no) 2005-11-17
EA013836B1 (ru) 2010-08-30
AU2004212704B2 (en) 2009-10-01
ATE490774T1 (de) 2010-12-15
NO20054296D0 (no) 2005-09-16
ZA200506580B (en) 2006-06-28
UY28193A1 (es) 2004-09-30
NZ541862A (en) 2008-04-30
IS7983A (is) 2005-08-15
SI1596862T1 (sl) 2011-03-31
TWI355936B (en) 2012-01-11
KR101113087B1 (ko) 2012-02-15
ECSP055970A (es) 2006-01-16
EP1596862A1 (en) 2005-11-23
HK1076402A1 (en) 2006-01-20
ES2357769T3 (es) 2011-04-29
EA200501318A1 (ru) 2006-02-24
MXPA05008757A (es) 2006-05-31
JP2006517944A (ja) 2006-08-03
MY143789A (en) 2011-07-15
US20060074101A1 (en) 2006-04-06
UA96254C2 (uk) 2011-10-25
DE602004030424D1 (de) 2011-01-20
EP2258367A2 (en) 2010-12-08
HRP20050709A2 (en) 2005-12-31
EP1596862B1 (en) 2010-12-08
DK1596862T3 (da) 2011-03-28
PT1596862E (pt) 2011-03-15
CU23587B7 (es) 2010-10-30
BRPI0407549A (pt) 2006-02-14
CY1111312T1 (el) 2015-08-05

Similar Documents

Publication Publication Date Title
GEP20104908B (en) Use of palonosetron treating post-operative nausea and vomiting
NL301145I1 (enExample)
WO2007140002A3 (en) Method for treating non-hodgkin's lymphoma
AU2003272285A8 (en) Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
WO2008069889A3 (en) Methods of treating hemolytic anemia
MXPA06014510A (es) Composiciones y metodos para tratar trastornos inflamatorios.
TW200745112A (en) Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators
MXPA04002983A (es) Derivados de quinuclidina, procedimientos para prepararlos y sus usos como inhibidores del receptor muscar??nico m2 y/o m3.
MX2009009290A (es) Compuestos activos en ppar.
WO2009080351A9 (en) Compounds with anti-emetic effect
WO2009155054A3 (en) 5-ht3 receptor modulators, methods of making, and use thereof
MXPA05007379A (es) Metodo para tratar nauseas, vomito, esfuerzo por vomitar o cualquier combinacion de los mismos.
GEP20115201B (en) Cinnamoyl-piperazine derivatives and their use as par- i antagonists
TNSN07165A1 (en) Organic compounds
MXPA04005003A (es) Antagonistas de endotelina en un metodo y composicion para potenciar un analgesico opiaceo.
CA2505990A1 (en) Palonosetron for the treatment of chemotherapy-induced emesis
WO2011008572A3 (en) 5-ht3 receptor modulators, methods of making, and use thereof
BRPI0412629A (pt) método de tratamento de disfunção ocular em mamìferos
WO2006011811A3 (en) Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process
WO2007024921A3 (en) Combination therapies for inhibiting integrin-extracellular matrix interactions
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
MXPA02012244A (es) 1-aminoalquilciclohexanos como 5-ht3 y antagonistas de receptor nicotinico neuronal.
TW200730530A (en) Lyophilized compositions of a triazolopyrimidine compound
WO2006016192A3 (en) Combination therapy with nk3 receptor antagonists for the treatment of schizophrenia
WO2005094798A3 (en) Pharmaceutical compositions based on anticholinergics and ccr2 receptor antagonists